Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-STX-478 is the S isomer of STX-478. STX-478 is a PI3Kα inhibitor that crosses the blood-brain barrier with oral activity, has anti-cancer properties, and inhibits tumor growth. It is suitable for studying breast cancer and other cancers.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $74 | In Stock | |
5 mg | $163 | In Stock | |
10 mg | $245 | In Stock |
Description | (S)-STX-478 is the S isomer of STX-478. STX-478 is a PI3Kα inhibitor that crosses the blood-brain barrier with oral activity, has anti-cancer properties, and inhibits tumor growth. It is suitable for studying breast cancer and other cancers. |
In vitro | STX-478 is a potent and selective inhibitor of all kinase domain mutant forms of PI3Kα found in cancer, with KD and IC50 values of H1047R and WT PI3Kα = 4.7 nmol/L (KD), respectively. 9.4 nmol/L (IC50) and 70 nmol/L (KD) 131 nmol/L (IC50). [1] |
In vivo | Treatment with STX-478 (100 mg/kg) produced powerful antitumor efficacy against PI3Kα mutant tumors in mice without metabolic dysregulation. [1] |
Alias | (S)-STX478 |
Molecular Weight | 401.29 |
Formula | C16H12F5N5O2 |
Cas No. | 2883540-91-6 |
Smiles | [C@@H](NC(NC=1C=NC(N)=NC1)=O)([C@](F)(F)F)C2=C(C)C=3C(O2)=C(F)C=C(F)C3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80.00 mg/mL (199.36 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.